ALSO NOTED: Archemix and Isis to collaborate; WuXi PharmaTech sees successful IPO; FDA ruling soon on Wyeth drug; and much more

> Archemix and Isis Pharmaceuticals have inked a deal to collaborate on aptamer drug discovery and development. Release

> WuXi PharmaTech can bank on a successful IPO. Its shares jumped 38 percent on its opening after it priced above expectations. Release

> An FDA ruling is looming for Wyeth's schizophrenia drug bifeprunox. Report

> A team of investigators says a new trial of an experimental stroke drug has demonstrated no effect. Report

> Jordan's Hikma Pharmaceuticals is buying Alkan Pharma in Egypt for $60.5 million. Report

> American Oriental Bioengineering is buying Guangxi Boke Pharmaceutical Company for $40 million. Release

> India's Biocon has inked a deal to commercialize Abraxis' Abraxane in India. Report

> Avexa says it is ready to launch a late-stage trial of ATC. Release

And Finally… Britain's rising rates of cancer are being linked to lifestyle choices like sunbathing, drinking and smoking. Report